Cellectar Biosciences Files Q1 2025 10-Q
Ticker: CLRB · Form: 10-Q · Filed: May 13, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
Cellectar Q1 2025 10-Q filed. Financials show $46M+ in assets, $1.8M in expenses.
AI Summary
Cellectar Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. Key financial data includes a reported value of $46,079,875 for certain items, with costs and expenses amounting to $1,820,000. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with an update on Cellectar Biosciences' financial health and operational status for the first quarter of 2025, crucial for understanding the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cellectar Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- $46.08B — Financial Value (Represents a significant reported financial figure for the period.)
- $1.82M — Costs and Expenses (Indicates operational spending during the reporting period.)
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250513 (date) — Filing date
- 46079875 (dollar_amount) — Reported financial value
- 1820000 (dollar_amount) — Costs and expenses
FAQ
What is the primary business of Cellectar Biosciences, Inc.?
Cellectar Biosciences, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 13, 2025.
What was the value reported for 'Costs and Expenses'?
The value reported for 'Costs and Expenses' was $1,820,000.
What is the fiscal year end for Cellectar Biosciences, Inc.?
Cellectar Biosciences, Inc.'s fiscal year ends on December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Cellectar Biosciences, Inc. (CLRB).